<code id='832928EFA9'></code><style id='832928EFA9'></style>
    • <acronym id='832928EFA9'></acronym>
      <center id='832928EFA9'><center id='832928EFA9'><tfoot id='832928EFA9'></tfoot></center><abbr id='832928EFA9'><dir id='832928EFA9'><tfoot id='832928EFA9'></tfoot><noframes id='832928EFA9'>

    • <optgroup id='832928EFA9'><strike id='832928EFA9'><sup id='832928EFA9'></sup></strike><code id='832928EFA9'></code></optgroup>
        1. <b id='832928EFA9'><label id='832928EFA9'><select id='832928EFA9'><dt id='832928EFA9'><span id='832928EFA9'></span></dt></select></label></b><u id='832928EFA9'></u>
          <i id='832928EFA9'><strike id='832928EFA9'><tt id='832928EFA9'><pre id='832928EFA9'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:48
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling.

          CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissions, and inpatient dialysis at our hospitals.”

          advertisement

          The DOJ initiates these investigations into health care companies when it believes there could be a False Claims Act case, but has not initiated or joined any lawsuits yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Merck CEO won’t testify in Senate, citing no expertise in drug prices
          Merck CEO won’t testify in Senate, citing no expertise in drug prices

          Sen.BernieSanderstoldreportersthatMerck'sCEOrefusedtotestifyoveralackofexpertiseindrugpricing.Mariam

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Experimental asthma app from Apple and Anthem shows promise

          ParticipantsinadigitalasthmastudyfromAppleandAnthemreceivedanAppleWatchandasleeptrackingmatthatareus